View of Efficacy of transcutaneous retrobulbar amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: A single-center retrospective observational study.

Return to Article Details Efficacy of transcutaneous retrobulbar amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: A single-center retrospective observational study. Download Download PDF